UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN C000000004
Receipt number R000000018
Scientific Title Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma(JCOG0110, GCSSG-SPNX)
Date of disclosure of the study information 2005/06/07
Last modified on 2017/11/08 18:13:56

No. Disposal Last modified on Item of update
1 Insert 2005/06/06 18:48:37
2 Update 2005/06/06 18:56:19 Key exclusion criteria
Key inclusion criteria
Key inclusion criteria
3 Update 2005/06/07 18:03:40 Date of disclosure of the study information
4 Update 2005/06/09 19:46:14 TEL

5 Update 2005/06/09 19:48:01 TEL

6 Update 2005/06/13 21:32:01 Email1
Email
7 Update 2005/06/13 21:41:12 Email
8 Update 2005/07/22 16:25:49 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Organization
Institute
Institute
Email1
9 Update 2005/07/22 16:26:30 Stratification
10 Update 2005/07/27 18:00:43 Trial characteristics_2
11 Update 2005/08/17 12:20:44 Public title
Public title
12 Update 2005/08/17 12:22:29 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
13 Update 2006/10/13 21:39:32 Recruitment status
14 Update 2007/01/10 13:43:00 Email1
15 Update 2007/11/27 15:45:21 Recruitment status
Anticipated trial start date
Last follow-up date
16 Update 2007/11/27 15:46:43 Condition
17 Update 2008/02/29 22:18:46 Last name of lead principal investigator
Organization
Organization
Address
Address
Email1
18 Update 2009/01/23 11:16:23 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
19 Update 2009/01/23 11:17:32 Key inclusion criteria
Key inclusion criteria
20 Update 2009/01/23 11:19:56 Division name
Division name
Division name
Division name
Address
Address
21 Update 2009/06/08 14:49:04 Name of person sending information
Name of person sending information
22 Update 2009/06/08 14:49:31 Recruitment status
23 Update 2012/06/27 14:42:54 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
24 Update 2014/06/19 14:18:30 Key secondary outcomes
Key secondary outcomes
25 Update 2014/06/19 14:30:59 TEL
Email
Division name
Division name
TEL
Organization1
Institutions
26 Update 2017/11/08 18:13:56 Recruitment status
Publication of results
URL related to results and publications
Results
Results